Trial Profile
Photodynamic therapy without curettage
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2018
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 06 Jan 2018 Status changed from recruiting to completed.
- 15 Jun 2017 New trial record